APTOFUSE

Serial Number 90677150
Registration 6975441
700

Registration Progress

Application Filed
Apr 28, 2021
Under Examination
Jun 7, 2022
Approved for Publication
Apr 12, 2022
Published for Opposition
Apr 12, 2022
Registered
Feb 7, 2023

Basic Information

Serial Number
90677150
Registration Number
6975441
Filing Date
April 28, 2021
Registration Date
February 7, 2023
Published for Opposition
April 12, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 7, 2023
Registration
Registered
Classes
005 010

Rights Holder

CLARIANCE SAS

99
Address
18 rue Robespierre
BEAURAINS 62217
FR

Ownership History

CLARIANCE SAS

Original Applicant
99
BEAURAINS FR

CLARIANCE SAS

Owner at Publication
99
BEAURAINS FR

CLARIANCE SAS

Original Registrant
99
BEAURAINS FR

Legal Representation

Attorney
Jeff Goehring

USPTO Deadlines

Next Renewal Deadline
1310 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-02-07)
Due Date
February 07, 2029
Grace Period Ends
August 07, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description
Feb 7, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 7, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 5, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 21, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Dec 19, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 1, 2022 EISU I TEAS STATEMENT OF USE RECEIVED
Dec 1, 2022 IUAF S USE AMENDMENT FILED
Jun 7, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 12, 2022 PUBO A PUBLISHED FOR OPPOSITION
Apr 12, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2021 CNRT R NON-FINAL ACTION WRITTEN
Dec 28, 2021 GNRT F NON-FINAL ACTION E-MAILED
Dec 28, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2021 DOCK D ASSIGNED TO EXAMINER
Aug 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medical, pharmaceutical and surgical products for nucleic acid implants of the spine, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; chemical substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; filling substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; bio-absorbable filling substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; injectable viscoelastic substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; injectable dermal filler in the nature of biocompatible silicone for nucleic acid implants
First Use Anywhere: Sep 1, 2022
First Use in Commerce: Sep 1, 2022
Class 010
Surgical nucleic implants for vertebrae; surgical nucleoarthoplasty implants for vertebrae; surgical nucleic implants based on filling substances for vertebrae; surgical implants for intervertebral discs; surgical nucleic implants based on injectable biocompatible silicone; surgical implants for intervertebral discs; surgical implants based on bone substitutes; bone substitutes, intervertebral bone substitutes, allograft bone substitutes, synthetic bone substitutes
First Use Anywhere: Sep 1, 2022
First Use in Commerce: Sep 1, 2022

Classification

International Classes
005 010